Diagnosis of prostate cancer (PC a) is currently much reliant on the invasive and time‐
consuming transrectal ultrasound‐guided biopsy of the prostate gland, particularly in light of …

Background A more specific and early diagnostics for prostate cancer (PCa) is highly
desirable. In this study, being inflammation the focus of our effort, serum protein profiles …

Background: The incidence of prostate cancer (PCa) has increased in recent years due to
the aging of the population and increased testing; however, mortality rates have remained …

Abstract Globally, Prostate cancer (PCa) is the most frequently occurring non-cutaneous
cancer, and is the second highest cause of cancer mortality in men. Serum prostate specific …

Purpose Early detection of prostate cancer (PC) using prostate‐specific antigen (PSA) in
blood reduces PC‐death among unscreened men. However, due to modest specificity of …

Prostate cancer (PCa) is one of the most common malignant tumors and a major cause of
cancer-related death for men worldwide. The aim of our study was to identify potential non …

PURPOSE: Prostate Cancer (PCa) represents the second most frequent type of tumor in
men worldwide. Incidence increases with patient age and represents the most important risk …

OBJECTIVE To describe the preliminary identification of serum proteins that may be
diagnostic markers in prostate cancer. PATIENTS AND METHODS The study included 11 …

Early detection of prostate cancer may lead to the overdiagnosis and overtreatment of
patients as well as missing significant cancers. The current diagnostic approach uses …

Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …